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Kaposi’s Sarcoma is a vascular tumour caused by the
Kaposi’s sarcoma-associated herpesvirus (KSHV).
Although KSHV and HIV co-infection is often observed in
HIV disease, the majority of patients nevertheless do not
develop KS. Innate immunity, and in particular human
leukocyte antigen alleles (HLA) and killer cell immunoglo-
bulin-like receptor (KIR) are suspected to play a role in
the development of viral associated carcinomas. We veri-
fied possible correlations between KIR/HLA complexes
and KS by analyzing 82 HIV subjects: 15 with KS (KSpos),
32 KSHV-infected without KS (KSHVpos/KSneg) and
35 KSHV-uninfected (KSHVneg/KSneg); results were
compared to those of 103 age-and sex-matched KHSV-
seronegative individuals (HC).
Molecular genotyped was performed by Single Specific
Primer (SSP) method for HLA class I, and KIR alleles.
Chi-square analysis Yates corrected (py) and Fisher
exact test (pf) were evaluated when appropriated.
Results showed a statistically higher frequency of the
activating KIR2DS2 allele i nK S p o ss u b j e c t s( 9 3 . 3 % )
than either in KSHVpos/KSneg (46.8%, py=0.02), or
KSHVneg/KSneg (51.4%,py=0.008) patients, and HC
(42.7%, py=0.02). Moreover, the homozygous genotype
KIR2DS2+/2DL2- was present in 3/15 KSpos, but in
none KSHVpos/KSneg (pf=0.03) or KSHVneg/KSneg
(pf=0.02) and only in 1/103 HC (pf=0.006).
Finally there was an higher frequency of KIR2DS2/
HLAC-1 functional complex in KSpos (66.7%) than in
all the other groups (40.6%, 40.0%, 43.7%, respectively),
though not statistically significant.
Results herein, although stemming from analyses per-
formed on a small number of individuals, suggest that
HIV and KSHV co-infected subjects in whom activating
KIRs and activating KIR-HLA ligands functional com-
plexes are detected, are more prone to develop KS.
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